CATHETER PRECISION, INC. Financials Catheter Precision, Inc.
Equities
VTAK
US74933X3026
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6075 USD | +1.25% |
|
+10.25% | +50.26% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 2.841 | 4.544 | - | - |
| Enterprise Value (EV) 1 | 2.841 | 4.544 | 4.544 | 4.544 |
| P/E ratio | -0.03 x | -0.69 x | -1.58 x | -8.57 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 1.42 x | 0.51 x | 0.26 x |
| EV / Revenue | - | 1.42 x | 0.51 x | 0.26 x |
| EV / EBITDA | - | - | - | - |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 7,027 | 7,573 | - | - |
| Reference price 2 | 0.4043 | 0.6000 | 0.6000 | 0.6000 |
| Announcement Date | 01/04/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 3.19 | 8.85 | 17.26 |
| EBITDA | - | - | - | - |
| EBIT 1 | - | -7.79 | -5.44 | -1.26 |
| Operating Margin | - | -244.2% | -61.47% | -7.3% |
| Earnings before Tax (EBT) 1 | - | -7.79 | -5.44 | -1.26 |
| Net income 1 | -70.57 | -7.79 | -5.44 | -1.26 |
| Net margin | - | -244.2% | -61.47% | -7.3% |
| EPS 2 | -12.99 | -0.8700 | -0.3800 | -0.0700 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 01/04/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 5 | 0.082 | 0.29 | 1.06 | 1.66 | 1.46 | 1.61 |
| EBITDA | - | - | - | - | - | - | - |
| EBIT 1 | - | -2.616 | -2.1 | -1.8 | -1.39 | -2.04 | -1.55 |
| Operating Margin | - | -3,190.24% | -724.14% | -169.81% | -83.73% | -139.73% | -96.27% |
| Earnings before Tax (EBT) 1 | - | -2.675 | -2.1 | -1.8 | -1.39 | -2.04 | -1.55 |
| Net income 1 | - | -2.675 | -2.1 | -1.8 | -1.39 | -2.04 | -1.55 |
| Net margin | - | -3,262.2% | -724.14% | -169.81% | -83.73% | -139.73% | -96.27% |
| EPS 2 | - | -0.3600 | -0.2600 | -0.1800 | -0.1200 | -0.1600 | -0.1100 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | - | 06/05/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex 1 | - | 0.4 | 0.5 | - |
| Capex / Sales | - | 12.54% | 5.65% | - |
| Announcement Date | 01/04/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6
USD
Average target price
4.1
USD
Spread / Average Target
+583.33%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +50.26% | 45.44L | |
| +11.29% | 23TCr | |
| +8.76% | 19TCr | |
| +12.90% | 14TCr | |
| +25.95% | 11TCr | |
| +0.34% | 6.32TCr | |
| +11.08% | 5.23TCr | |
| +5.62% | 5.1TCr | |
| +6.28% | 4.39TCr | |
| +4.80% | 3.81TCr |
- Stock Market
- Equities
- VTAK Stock
- Financials Catheter Precision, Inc.
